Shanghai Rendu Biotechnology
Shanghai Rendu Biotechnology Co., Ltd. operates as a biotechnology company
About Shanghai Rendu Biotechnology
RDBio specializes in advanced diagnostic solutions, focusing on simultaneous amplification and testing (SAT) technologies to enhance the accuracy and speed of disease detection. The company serves healthcare providers, laboratories, and research institutions, primarily operating in the medical diagnostics market. RDBio's business model revolves around the development, manufacturing, and distribution of SAT-based diagnostic kits and equipment. Revenue is generated through the sale of these products, as well as through partnerships and licensing agreements. The company's innovative approach aims to improve diagnostic outcomes, particularly in the detection of infectious diseases such as Mycoplasma pneumoniae and tuberculous pleurisy.
Source: Dealroom company dataNews
Open roles
Shanghai Rendu Biotechnology in the Huangpu ecosystem
The Shanghai Rendu Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shanghai Rendu Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shanghai Rendu Biotechnology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


